Legal Representation
Attorney
Bernhard P Molldrem Jr
USPTO Deadlines
Next Deadline
793 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-01-04)
Due Date
January 04, 2028
Grace Period Ends
July 04, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
20 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 4, 2022 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Nov 30, 2021 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Nov 29, 2021 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Oct 29, 2021 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Oct 29, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Oct 12, 2021 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Oct 12, 2021 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Sep 28, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Aug 3, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Aug 3, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jul 14, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jun 25, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jun 25, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 25, 2021 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jun 25, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jun 25, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jun 24, 2021 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Mar 23, 2021 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Mar 22, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 1, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
pharmaceutical preparations, namely, pharmaceutical preparations for treating allergies, colds and coughs, pain relief, treatment of digestive disorders; pharmaceutical preparations for treating stomach disorders, respiratory disorders, dermatological disorders; dietary supplements, namely, vitamins and mineral supplements, dietary immune support supplements
First Use Anywhere:
Jul 1, 2021
First Use in Commerce:
Jul 1, 2021
Additional Information
Design Mark
The mark consists the term "MEDIBEST" in lower case letters with a curved line with pointed ends, beneath the term extending from the "M" to the space between the "S" and the "T," and two ogive leaves at the right end of the curved line with one leaf partly obscured behind the "S" and the other in front of and partly obscuring the "S" and the "T".
Pseudo Mark
MEDI BEST
Classification
International Classes
005